Efficient no-code solution with its own IDE for easier development.

These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

We asked startup founders, recruiters, and hiring managers what to do — and not to do — to boost your chances of getting an offer.

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...